Quantessence Capital LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 2009590
NEW YORK, NY
Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,723
New position
Shares Held
16,281
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quantessence Capital LLC holds $628,457 across 7 Biotechnology names. LCTX ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,063 | $206,400 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
5,121 | $206,017 | |
| 3 | ATAI |
AtaiBeckley Inc.
|
25,311 | $89,600 | |
| 4 | OCGN |
Ocugen, Inc.
|
25,952 | $46,973 | |
| 5 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
18,581 | $28,986 | |
| 6 | LCTX |
Lineage Cell Therapeutics, Inc.
This page
|
16,281 | $25,723 | |
| 7 | IVVD |
Invivyd, Inc.
|
19,045 | $24,758 |
All Filings in LCTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,723 | 16,281 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||